Mergers and Acquisitions in the IVD Market

    Published: January 10, 2017 | Price: $796.00 – $1,592.00

    Mergers and Acquisitions in the IVD Market Mergers and Acquisitions (M&A) activity in the in vitro diagnostics (IVD) market was brisk in 2016. Kalorama's report records 250 acquisitions in the industry from 2013-2016. Becton Dickinson (BD), Danaher, Roche, and Thermo Fisher Scientific were among the companies active in M&A during this period.
    Computed Tomography (CT) Markets

    Published: January 5, 2017 | Price: $3,600.00 – $7,200.00

    Computed Tomography (CT) Markets Computed Tomography (CT) Markets focuses on the worldwide opportunity for computed tomography, including data on global revenue for medical CT systems, 2016-2021; major competitors’ percentage share of the global revenue for medical CT systems, 2016; global revenue geographic share for medical CT systems, 2016 (US, Europe, China, Brazil, Asia Pacific [APAC], ROW); and future CT regional revenue growth trends. The report outlines trends, challenges and issues, and major developments in this modality’s market. Analogic, Arineta, Bayer,...
    Autoimmune IVD Testing Market

    Published: October 11, 2016 | Price: $3,360.00 – $6,720.00

    Autoimmune IVD Testing Market This report provides important business planning information for in vitro diagnostic testing products, instruments and supplies used in the detection of autoimmune disease. The report includes market sizing and forecasts, regional markets, markets by type - including arthritis, thyroid, gastrological disease, SLE, and others. The report also details new innovations in testing and profiles companies in the market. The following companies are covered. Revenues, test product, and significant competitive moves are included: Thermo Fisher WerfenLife, Alere,...
    IVD in the Middle East (Egypt, Turkey, Saudi Arabia, United Arab Emirates, Israel, Jordan, Other Mideast)

    Published: October 4, 2016 | Price: $2,396.00 – $4,792.00

    IVD in the Middle East (Egypt, Turkey, Saudi Arabia, United Arab Emirates, Israel, Jordan, Other Mideast)    In vitro diagnostic (IVD) companies are casting their nets in developing countries, where rising incomes and standards of living have sparked a new health consciousness and growing demands for quality medical care. The Middle East is an underserved region with large market potential. IVD in the Middle East provides data on the developments in the IVD industry in the Middle East, including: Egypt...
    The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 10th Edition (Core Lab, POC, Glucose, Infectious Disease Testing, Histology, Hematology, NGS, Blood Screening/Typing, Coagulation Tests, Other Markets and Trends)

    Published: August 22, 2016 | Price: $3,600.00 – $7,200.00

    This Kalorama Information report, The Worldwide Market for In Vitro Diagnostic Tests, represents the 10th edition of this comprehensive look at the IVD industry.   At 1,600 pages report provides market size estimates and projections for the entirety of the clinical diagnostics testing market.  It also profiles hundreds of competitors, notes significant acquisitions and other deals, discusses trends and breaks out regional and country markets.   The report provides market size and forecasts to 2021 for defined segments of the IVD...
    The World Market for Point of Care (POC) Diagnostics and The Market for Molecular POC Diagnostics

    Published: July 28, 2016 | Price: $6,000.00 – $12,000.00

    This combined report offering allows customers of Kalorama research to have two titles, combining Kalorama's authoritative volume covering the entire world POC market with its more focused report on molecular POC systems. The World Market for Point of Care (POC) Diagnostics presents current analysis of the POC diagnostics industry and the role it plays in medical practice. This report takes an in-depth look at the POC diagnostic testing market, both professional and self-testing. The report provides data on the size...
    United States Market for In Vitro Diagnostic Tests (Molecular Assays, Microbiology, Histology, Chemistry, Hematology, Blood Banking, POC and Other Tests)

    Published: June 27, 2016 | Price: $3,196.00 – $6,720.00

    United States Market for In Vitro Diagnostic Tests United States Market for In Vitro Diagnostic Tests takes a considered look at the U.S. in vitro diagnostics (IVD) market and examines what current market trends mean for diagnostic manufacturers and investors. This report includes important tools for business planners. Included are market size estimates and forecasts for the following U.S. IVD segments: Clinical Chemistry Market (2015/2020) Identification and Antibiotic Susceptibility Testing (ID/AST) Microbiology (Traditional) Market – Automated ID/AST, Manual/Semi‐Auto ID/AST, Blood...
    The World Market for Companion Diagnostic Tests

    Published: June 7, 2016 | Price: $3,360.00 – $6,720.00

    The World Market for Companion Diagnostics The World Market for Companion Diagnostics examines revenues for companion diagnostic and personalized medicine diagnostics. Market analysis in this market review includes regional coverage – North America, Europe, rest of world – of the world IVD companion diagnostics test market (in vitro diagnostic kits) for 2015-2020, coverage by disease segment – cancer and other – of the world IVD companion diagnostics test market for 2015, and coverage of the worldwide companion diagnostics test services...
    Blood Testing Market in China (Typing, Immunoassay, NAT Testing)

    Published: April 20, 2016 | Price: $2,000.00 – $4,000.00

    Blood Testing Market in China (Typing, Immunoassay, NAT Testing) With a population of more than 1 billion, China is the world’s largest country and therefore also its single largest potential market for goods and services. Blood Testing Market in China offers the most current look at the blood testing IVD market in China, including tests for blood typing, immunoassay-based tests and NAT Tests. The report provides market analysis and data on the blood testing market environment in China, including: Blood...
    Cancer Markers

    Published: March 24, 2016 | Price: $2,000.00 – $4,000.00

    Cancer Markers Cancer Markers contains revenue assessment, analysis, and competitive review for tests for oncology using biomarkers. Multiple firms manufacture a range of technologies – histology/cytology, immunohistochemistry, in situ hybridization, immunoassays - tumor markers, flow cytometry, rapid tests, and molecular marker-based technologies – to determine risk for cancer, screen for cancer, test for cancer, and help in prognosis and personalization of therapy. Cancer Markers provides the following information: global cancer biomarkers diagnostic revenues, 2015 and 2020 (IHC, ISH, immunoassays, flow,...
    The Market and Potential for Molecular Point of Care Diagnostics: Revenue Forecasts to 2020

    Published: February 26, 2016 | Price: $3,360.00 – $6,720.00

    Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics, and community health posts in the developing world.bThe Market and Potential for Molecular Point of Care Diagnostics examines the major segments of molecular POC diagnostics, exploring in-depth  current sales and market opportunity and providing the following market information: Molecular POC Market for...
    Novel Autism Diagnostics

    Published: February 5, 2016 | Price: $2,000.00 – $4,000.00

    Novel Autism Diagnostics Novel Autism Diagnostics reviews selected autism test innovations, summarizing many of the current approaches to autism diagnostics, which include molecular testing, pre-disposition screening, targeted sequencing-based testing, next-generation sequencing with modeling, genetic risk assessment / testing, cloud platform approaches, microarrays, end-to-end sequencing, gene variants, and blood-based genetic testing. The report looks at the companies behind these testing approaches as well. Asuragen, Google Genomics, Illumina, and LabCorp are among the companies discussed within the report’s competitive analysis.
    POC Cholesterol Testing Market

    Published: January 26, 2016 | Price: $796.00 – $1,592.00

    Point of Care (POC) Cholesterol Testing Market Point of Care (POC) Cholesterol Testing Market presents the revenue picture for cholesterol testing performed at or near the site where the patient is located. The following data regarding the POC cholesterol market are provided: world POC cholesterol testing revenue estimates, 2012-2020; POC cholesterol self-testing revenue estimates, 2015 and 2020; POC cholesterol professional testing revenue estimates, 2015 and 2020; world POC cholesterol testing revenue estimates and market share of leading manufacturers, 2014; and...
    World In Vitro Diagnostics (IVD) Market Bundle: Molecular Diagnostics (Microbiology, Oncology, Blood, Prenatal, Inherited, Others), Cancer Diagnostics (HPV, ISH, Cytometry, PSA, FOB, Others), Infectious Diseases (ID/AST, POC, HAIs, STDs, Other)

    Published: January 22, 2016 | Price: $3,600.00 – $6,320.00

    This Kalorama Information In Vitro Diagnostics (IVD) Market Bundle represents three reports, as published in 2015. These reports, representing over 2,000 pages of market information, delve into some of the fastest-growing and most critical areas of clinical diagnostics: cancer diagnostics, molecular assays and systems, and infectious disease tests.  Together, these three in vitro diagnostic areas represent nearly one-half of the IVD market and the best growth opportunities. The Bundle features the exact published content in each of the three major Kalorama...
    Blood Screening and Typing Markets

    Published: January 20, 2016 | Price: $2,000.00 – $4,000.00

    Blood Screening and Typing Markets Blood Screening and Typing Markets analyzes the infectious disease blood typing and the infectious disease blood screening opportunities, including complete revenue estimates of the blood screening and typing markets: global blood typing and screening revenues, 2015 and 2020 (ABO grouping, immunoassay screen, NAT screen); selected blood typing innovations; blood typing by country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%); infectious disease blood typing market portion by...